Online citations, reference lists, and bibliographies.

Pharmacokinetic Interaction Of Ketoconazole And Itraconazole With Ciprofloxacin.

Hisham S. Abou-Auda, Ali Ahmed Mustafa, M S Alhumayyd
Published 2008 · Medicine, Chemistry
Cite This
Download PDF
Analyze on Scholarcy
Share
The effect of the concomitant administration of the antifungal drugs ketoconazole (KTC) and itraconazole (ITC) on the pharmacokinetics of ciprofloxacin (CIP) following short- and long-term administration in mice was investigated. Animals received either a dose of CIP (20 mg/kg, i.p.), CIP (20 mg/kg, i.p.) together with KTC (50 mg/kg, p.o.) or CIP (20 mg/kg, i.p.) and ITC (30 mg/kg, p.o.). The same treatments were repeated for 7 days. Blood samples were collected up to 4 h following drug administration and two urine samples were collected at 2 h and 4 h after drug administration. CIP plasma concentrations were significantly higher in KTC- and ITC-treated groups compared with the corresponding control groups. The concomitant administration of KTC or ITC with CIP also significantly (p<0.05) increased C(max), t(1/2), MRT and AUC(0-infinity) with no change in T(max). CIP clearance was significantly reduced by both agents. KTC and ITC reduced CIP urinary excretion. This study suggests that an important pharmacokinetic interaction between CIP and KTC or ITC is likely to occur when either of the two antifungal drugs is administered concomitantly with CIP. The results may suggest possible reductions in total clearance of CIP, owing to inhibition of its renal tubular excretion by KTC and ITC.
This paper references
10.2165/00003495-199651060-00010
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.
R Davis (1996)
10.2165/00002018-200022060-00006
Fluoroquinolone-Induced Renal Failure
Ben M. Lomaestro (2000)
10.2165/00002018-199818020-00001
Systemic Antifungal Agents
Edith Albengres (1998)
10.1038/clpt.1994.60
Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole
Klaus T. Olkkola (1994)
10.1038/clpt.1994.184
Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole.
A Varhe (1994)
479–485
Lomaestro BM. Fluoroquinolone-induced renal failure. Drug Sa 2000 (2008)
10.1093/jac/26.suppl_B.51
Pharmacokinetics of quinolones in renal insufficiency.
Jean Paul Fillastre (1990)
10.1007/BF01062109
Statistical moments in pharmacokinetics
Kiyoshi Yamaoka (2005)
10.1177/106002809703100410
Digoxin–Itraconazole Interaction: Possible Mechanisms
Christopher P Alderman (1997)
Ciprofloxacin therapy in cystic fibrosis.
B E Scully (1987)
Ketoconazole labeling revised.
(1984)
372–373
Mayersohn M. Noncompartmental determination of the steady-st Perrier D (2008)
10.1002/(SICI)1099-081X(199904)20:3<145::AID-BDD167>3.0.CO;2-H
Effect of itraconazole on the pharmacokinetics of digoxin in guinea pigs.
Kazuhiro Nishihara (1999)
10.1007/s002280000192
Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia
Kari Raaska (2000)
10.1111/j.1365-2885.2005.00698.x
Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs.
N L Regmi (2005)
Characteristics of intraconazole and ketoconazole inhibition of digoxin transport across renal tubular cells
S Ito (1995)
Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
Tone Bergan (1987)
10.1128/AAC.31.5.709
Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function.
T. Christian Gasser (1987)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar